{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:52:10Z","timestamp":1785858730305,"version":"3.56.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1097\/01.gco.0000180659.09320.3e","type":"journal-article","created":{"date-parts":[[2005,9,13]],"date-time":"2005-09-13T04:27:53Z","timestamp":1126585673000},"page":"512-518","source":"Crossref","is-referenced-by-count":5,"title":["Intravesical injection of botulinum toxin for the treatment of overactive bladder"],"prefix":"10.1097","volume":"17","author":[{"given":"Mat H","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence L","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra L","family":"Haessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narender N","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210128","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1464-410X.2003.04714.x","article-title":"Botulinum toxin and its applications in the lower urinary tract","volume":"93","author":"Harper","year":"2004","journal-title":"BJU Int"},{"issue":"Suppl 6","key":"R2-12-20210128","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1093\/ajhp\/61.suppl_6.S5","article-title":"Pharmacology of botulinum neurotoxin serotype A","volume":"61","author":"Wenzel","year":"2004","journal-title":"Am J Health Syst Pharm"},{"key":"R3-12-20210128","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/00042307-200411000-00006","article-title":"Botulinum toxin in the management of lower urinary tract dysfunction: contemporary update","volume":"14","author":"Cruz","year":"2004","journal-title":"Curr Opin Urol"},{"key":"R4-12-20210128","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/nau.20090","article-title":"Botulinum toxin for the treatment of lower urinary tract symptoms: a review","volume":"24","author":"Sahai","year":"2005","journal-title":"Neurourol Urodyn"},{"key":"R5-12-20210128","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1097\/01.ju.0000127725.48479.89","article-title":"Emerging role of botulinum toxin in the management of voiding dysfunction","volume":"171","author":"Smith","year":"2004","journal-title":"J Urol"},{"key":"R6-12-20210128","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ncpuro0034","article-title":"Botulinum toxin in urology: evaluation using an evidence-based medicine approach","volume":"1","author":"Smith","year":"2004","journal-title":"Nat Clin Pract Urol"},{"key":"R7-12-20210128","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.urology.2004.03.007","article-title":"Botulinum toxin: a new dimension in the treatment of lower urinary tract dysfunction","volume":"64","author":"Rajkumar","year":"2004","journal-title":"Urology"},{"issue":"Suppl 8","key":"R8-12-20210128","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1002\/mds.20068","article-title":"Botulinum toxin in neuro-urological disorders","volume":"19","author":"Jost","year":"2004","journal-title":"Mov Disord"},{"key":"R9-12-20210128","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0302-2838(03)00250-1","article-title":"Botulinum toxin as a new therapy option for voiding disorders: current state of the art","volume":"44","author":"Leippold","year":"2003","journal-title":"Eur Urol"},{"key":"R12-12-20210128","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s11916-002-0065-y","article-title":"Botulinum toxin for the treatment of musculoskeletal pain and spasm","volume":"6","author":"Sheean","year":"2002","journal-title":"Curr Pain Headache Rep"},{"key":"R13-12-20210128","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0022-5347(05)67283-7","article-title":"Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results","volume":"164","author":"Schurch","year":"2000","journal-title":"J Urol"},{"key":"R14-12-20210128","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0302-2838(03)00136-2","article-title":"Botulinum: a toxin detrusor injection as a novel approach in the treatment of bladder spasticity in children with neurogenic bladder","volume":"44","author":"Schulte-Baukloh","year":"2003","journal-title":"Eur Urol"},{"key":"R16-12-20210128","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.eururo.2003.12.004","article-title":"European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity","volume":"45","author":"Reitz","year":"2004","journal-title":"Eur Urol"},{"key":"R17-12-20210128","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.urology.2003.12.007","article-title":"Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents","volume":"63","author":"Kuo","year":"2004","journal-title":"Urology"},{"key":"R18-12-20210128","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.urology.2004.01.041","article-title":"Use of botulinum-A toxin for the treatment of refractory overactive bladder symptoms: an initial experience","volume":"63","author":"Rapp","year":"2004","journal-title":"Urology"},{"key":"R19-12-20210128","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/01.ju.0000132152.53532.5d","article-title":"Intravesical resiniferatoxin versus botulinum\u2013A toxin injections for neurogenic detrusor overactivity: a prospective randomized study","volume":"172","author":"Giannantoni","year":"2004","journal-title":"J Urol"},{"key":"R20-12-20210128","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0003-9993(03)00202-8","article-title":"Use of botulinum toxin type B for the treatment of detrusor hyperreflexia in a patient with multiple sclerosis: a case report","volume":"84","author":"Dykstra","year":"2003","journal-title":"Arch Phys Med Rehabil"},{"issue":"Suppl 1","key":"R21-12-20210128","first-page":"A526","article-title":"Botulinum toxin type A intravesical injections for intractable bladder overactivity [Abstract]","volume":"1","author":"Radziszewski","year":"2002","journal-title":"Eur Urol"},{"key":"R22-12-20210128","first-page":"69","article-title":"The use of botulinum toxin A in children with a non-neurogenic overactive bladder: a pilot study","volume":"93","author":"Verleyen","year":"2004","journal-title":"BJU Int"},{"key":"R23-12-20210128","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/nau.20105","article-title":"Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity?","volume":"24","author":"Kessler","year":"2005","journal-title":"Neurourol Urodyn"},{"key":"R25-12-20210128","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00192-003-1099-3","article-title":"Treatment of overactive bladder with botulinum toxin type B: a pilot study","volume":"14","author":"Dykstra","year":"2003","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"R26-12-20210128","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1464-410X.2003.04312.x","article-title":"A minimally invasive technique for outpatient local anaesthetic administration of intradetrusor botulinum toxin in intractable detrusor overactivity","volume":"92","author":"Harper","year":"2003","journal-title":"BJU Int"},{"key":"R27-12-20210128","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.eururo.2004.07.011","article-title":"Lack of ultrastructural detrusor changes following endoscopic injection of botulinum toxin type A in overactive neurogenic bladder","volume":"46","author":"Haferkamp","year":"2004","journal-title":"Eur Urol"},{"key":"R28-12-20210128","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.eururo.2004.11.009","article-title":"Success of repeat detrusor injections of botulinum A toxin in patients with severe neurogenic detrusor overactivity and incontinence","volume":"47","author":"Grosse","year":"2005","journal-title":"Eur Urol"},{"key":"R29-12-20210128","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1136\/jnnp.2003.035139","article-title":"The beneficial antispasticity effect of botulinum toxin type A is maintained after repeated treatment cycles","volume":"75","author":"Bakheit","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R30-12-20210128","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/01.ju.0000108844.10235.f1","article-title":"Botulinum toxin type B for type A resistant bladder spasticity","volume":"171","author":"Pistolesi","year":"2004","journal-title":"J Urol"},{"key":"R31-12-20210128","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/01.ju.0000108407.53880.6a","article-title":"Botulinum toxin type B injection for management of type A resistant neurogenic detrusor overactivity","volume":"171","author":"Reitz","year":"2004","journal-title":"J Urol"},{"key":"R32-12-20210128","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.sc.3101736","article-title":"Adverse events after botulinum A toxin injection for neurogenic voiding disorders","volume":"43","author":"De Laet","year":"2005","journal-title":"Spinal Cord"},{"key":"R33-12-20210128","first-page":"24","article-title":"Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study","volume":"71","author":"Dykstra","year":"1990","journal-title":"Arch Phys Med Rehabil"},{"key":"R34-12-20210128","first-page":"522","article-title":"Botulinum A toxin in the treatment of detrusor hyperreflexia","volume":"20","author":"Del Popolo","year":"2001","journal-title":"Neurourol Urodyn"},{"key":"R35-12-20210128","first-page":"387","article-title":"Effectiveness of periurethral botulinum toxin injection in the treatment of voiding dysfunction due to detrusor underactivity and non-relaxing urethra","volume":"21","author":"Kuo","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"R36-12-20210128","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/sj.sc.3101318","article-title":"Muscular weakness as side effect of botulinum toxin injection for neurogenic detrusor overactivity","volume":"40","author":"Wyndaele","year":"2002","journal-title":"Spinal Cord"}],"container-title":["Current Opinion in Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00003246-200509000-00022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:57:31Z","timestamp":1785855451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001703-200510000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.gco.0000180659.09320.3e","relation":{},"ISSN":["1040-872X"],"issn-type":[{"value":"1040-872X","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}